Skip to content

Press Releases

Imbed Biosciences Extends Series A Financing to $4 Million to Commercialize Innovative Bioresorbable Bandage

MADISON, WI, NOVEMBER 5, 2019 Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed its Series A Preferred Stock equity financing, which… Read More »Imbed Biosciences Extends Series A Financing to $4 Million to Commercialize Innovative Bioresorbable Bandage

Imbed Biosciences Closes $2 Million in Series A Financing to Commercialize Wound Healing Matrix

MADISON, WI, APRIL 18, 2018 Imbed Biosciences, Inc. (Imbed), a medical device company emerging as a leader in the development of advanced therapies for soft tissue repair, announced today that it has secured $2 million in a Series A Preferred Stock equity financing. The funding… Read More »Imbed Biosciences Closes $2 Million in Series A Financing to Commercialize Wound Healing Matrix